You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Dipyridamole - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for dipyridamole and what is the scope of freedom to operate?

Dipyridamole is the generic ingredient in three branded drugs marketed by Chartwell Injectable, Dr Reddys, Eugia Pharma Speclts, Fresenius Kabi Usa, Hikma, Hospira, Boehringer Ingelheim, Ani Pharms, Barr, Chartwell Rx, Glenmark Generics, Impax Labs, Oxford Pharms, Purepac Pharm, Rising, Watson Labs, and Zydus Pharms Usa Inc, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for dipyridamole. Nine suppliers are listed for this compound.

Summary for dipyridamole
Drug Prices for dipyridamole

See drug prices for dipyridamole

Recent Clinical Trials for dipyridamole

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Guo-Qing JiangN/A
Clear Creek Bio, Inc.Phase 2
Rutgers, The State University of New JerseyPhase 3

See all dipyridamole clinical trials

Pharmacology for dipyridamole
Medical Subject Heading (MeSH) Categories for dipyridamole

US Patents and Regulatory Information for dipyridamole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc DIPYRIDAMOLE dipyridamole TABLET;ORAL 040874-001 Jan 28, 2008 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Barr DIPYRIDAMOLE dipyridamole TABLET;ORAL 087717-001 Oct 3, 1990 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Oxford Pharms DIPYRIDAMOLE dipyridamole TABLET;ORAL 040542-001 Apr 21, 2006 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Barr DIPYRIDAMOLE dipyridamole TABLET;ORAL 087716-001 Oct 3, 1990 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.